MedTrace Logo

The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes

NCT00327236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2019-04-10

No results posted yet for this study

Summary

The investigators believe that T cells, cells that are a part of the immune system, are what are causing the neurological problems while also attacking tumor cells. This protocol studies the clinical status of patients with paraneoplastic neurological disorder (PND) as well as their blood to understand the relationship between their neurological disease, their cancer, and their immune system.

Conditions

  • Paraneoplastic Syndromes

Sponsors & Collaborators

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Robert Darnell, MD, PHD · Rockefeller University

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327236 on ClinicalTrials.gov